Skip to main content
. 2014 Apr 30;8(1):327–334. doi: 10.3892/ol.2014.2107

Figure 1.

Figure 1

Survival curve of the 268 NSCLC patients with distant metastasis who had undergone first-line chemotherapy between January 1, 2004, and December 31, 2007. The median survival time (MST) was 14 months (95% confidence interval, 11.4–15.3 months). NSCLC, non-small cell lung cancer.